Among those speaking at the republican jewish coalitions 2023 Leadership Conference in las watch live at noon eastern on cspan saturday, or online at cspan. Org. Up next, testimony on access to research and treatment for patients with Rare Diseases. Advocates for medical ethics and therapeutic industry professionals also testified to provide insight on the fda Clinical Trial process. This hearing with the Senate Special Legion Committee is about two hours. With the Senate Special aging committee is about two hours. Good morning. Welcome to the committees eighth hearing of the 1 18 congress about Drug Development for rare and serious diseases. As is the tradition of the committee, the aging Committee Ranking member, Ranking Member braun in this case, will offer an opening statement. Ranking member braun thank you, senator. I thank the witnesses for coming and for all the folks from around the country who are here today. There are over 7000 rare and serious diseases known to man. Its est
Patients with Rare Diseases. Advocates for medical ethics and a therapeutic industry professionals also testified to provide insight on the fda Clinical Trial process. This hearing before the Senate Special Agent Committee is about two hours. [background noises] [background noises] good morning the Senate Special committee will come to order welcome everybody. Welcome to the committees eighth hearing of the one her 18th congress about Drug Development for rare and serious diseases. As is the tradition of the committee, the aging Committee Ranking member, Ranking Member brought in this case will offer an opening statement. Thank you, senator. Thank the witnesses for coming and for all of the folks from around the country here today. There are over 7000 rare progressive and serious diseases known to man. It is estimated 95 black treatment. Yet in my time et cetera there is not been one Senate Hearing to examine promising therapies for people with rare progressive and serious diseases. Th
Scene from beloved drones must seem like an angels of death. The gods can see you. All the time. A toy has turned into a deadly weapon. Has this become our god. Tell of the five the white city so far away from and yet so near to war at the beginning of our journey i want to visit a country that is mentally and often physically at war. And he saw his name on the news about my sure that i thought he had somewhere like we are in Israel Aerospace industry was one of the leading manufacturers of drones the day the army and his two colleagues invented something here four decades ago they call themselves the three musketeers without it. And the three of you this is your first three of it im sure this is was the first that will be getting in seventy seven. And nineteen seventy seven where we began to develop it from scratch so mean nothing was happening and we were thinking we knew with that we have to do a flying camera so we will begin to think about it and then this is it three years after
Challenges for American Health care. This is about 90 minutes. Thank you all for coming back after the break. Appreciate it. Hi. Im david im the ceo of specific Business Group on health. First i want to thank them for sponsoring this meeting for us. It is across many points of view they have a strong stake for their own populations and for everybody in the country. Its important to note that while these are tremendous organizations that are investing a great deal in experimentation and learning they are not typical of american employers. Any small and medium sized employees around the country to influence health care. I think one thing well talk about is the implications for these kinds of strategies for other employers who have the same resources to effect the market. We think theres a lot to be learned. What i want to do is take a minute to transition between the first panel and the second and mention a few of the themes i think we have heard. We talk about implications for the marke
Challenges for American Health care. This is about 90 minutes. Thank you all for coming back after the break. Appreciate it. Hi. Im david im the ceo of specific Business Group on health. First i want to thank them for sponsoring this meeting for us. It is across many points of view they have a strong stake for their own populations and for everybody in the country. Its important to note that while these are tremendous organizations that are investing a great deal in experimentation and learning they are not typical of american employers. Any small and medium sized employees around the country to influence health care. I think one thing well talk about is the implications for these kinds of strategies for other employers who have the same resources to effect the market. We think theres a lot to be learned. What i want to do is take a minute to transition between the first panel and the second and mention a few of the themes i think we have heard. We talk about implications for the marke